Innobiochips, founded in 2008 and headquartered in France, is a biotechnology and manufacturing company. The company specializes in developing the SirYus technology, a disruptive approach to designing, manufacturing, and reading multiplex immunoassays. This technology paves the way for innovative diagnostics solutions in human health, with a focus on areas such as transplantation, transfusion, infectious diseases, and the microbiome. The company received non-equity assistance investment from Eurasante on 21 July 2008. Innobiochips aims to revolutionize in vitro diagnostics, offering fast, reliable, and powerful solutions that take diagnostic capabilities to the next level.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | Unknown | 1 | Eurasante | 21 Jul 2008 |
No recent news or press coverage available for Innobiochips.
We care about your data, and we'd love to use cookies make your experience better.
